Development of a Nephrotic Syndrome in a Patient with Gastrointestinal Stromal Tumor during a Long-Time Treatment with Sunitinib

Development of a Nephrotic Syndrome in a Patient with Gastrointestinal Stromal Tumor during a Long-Time Treatment with Sunitinib

A patient with advanced gastrointestinal stromal tumor (GIST) receiving second-line treatment with sunitinib developed edema, increase of the serum creatinine, weight gain, nephrotic syndrome with proteinuria of 12 g/24 h, dyslipidemia, hypoalbuminemia and also presented with hypertension. A kidney...

Full description

Bibliographic Details
Main Authors: Maria Caterina Pallotti, Maria Abbondanza Pantaleo, Margherita Nannini, Francesca Centofanti, Benedetta Fabbrizio, Mara Montanari, Olga Baraldi, Maristella Saponara, Cristian Lolli, Anna Mandrioli, Guido Biasco, Rita Prandini
Format: Article
Language:English
Published: Karger Publishers 2012-12-01
Series:Case Reports in Oncology
Subjects:
Nephrotic syndrome
Vascular endothelial growth factor
Proteinuria
Renal toxicity
Gastrointestinal stromal tumor
Sunitinib
Online Access:http://www.karger.com/Article/FullText/345946

Internet

http://www.karger.com/Article/FullText/345946

Similar Items